Log In
Print
BCIQ
Print
Print this Print this
 

S/GSK1265744

  Manage Alerts
Collapse Summary General Information
Company GlaxoSmithKline plc
DescriptionLong-acting parenteral integrase inhibitor
Molecular Target
Mechanism of ActionHIV integrase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHIV / AIDS
Indication DetailsTreat HIV infection
Regulatory Designation

Partner

Shionogi & Co. Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today